• education
Search

Ajovy

Ajovy

fremanezumab

Manufacturer:

Vetter Pharma

Distributor:

DKLL

Marketer:

Teva Pharma
Concise Prescribing Info
Contents
Fremanezumab
Indications/Uses
Prophylaxis of migraine in adults w/ at least 4 migraine days/mth.
Click to view Ajovy detailed prescribing information
Dosage/Direction for Use
SC Inj into areas of the abdomen, thigh or upper arm. 225 mg once mthly or 675 mg every 3 mth.
Click to view Ajovy detailed prescribing information
Overdosage
View Ajovy overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity.
Click to view Ajovy detailed prescribing information
Special Precautions
Do not administer by IV or IM. Discontinue administration if hypersensitivity reactions occur. Patients w/ certain major CV diseases. Avoid use during pregnancy. Lactation. Childn <18 yr.
Click to view Ajovy detailed prescribing information
Adverse Reactions
Inj site pain, induration & erythema. Inj site pruritus.
Click to view Ajovy detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Ajovy detailed prescribing information
Storage
View Ajovy storage conditions for details to ensure optimal shelf-life.
Description
View Ajovy description for details of the chemical structure and excipients (inactive components).
Action
View Ajovy mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD03 - fremanezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Ajovy soln for inj 225 mg/1.5 mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in